Symptoms and Endoscopic Results in Consideration of Pretreatment
|ClinicalTrials.gov Identifier: NCT00612404|
Recruitment Status : Completed
First Posted : February 11, 2008
Last Update Posted : February 11, 2008
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||16255 participants|
|Official Title:||Symptoms and Endoscopic Results in Consideration of Pretreatment|
|Study Start Date :||September 2005|
|Primary Completion Date :||December 2005|
patients with gastrointestinal disorders who need an endoscopy.
- to gain insight into the relationship between subjective gastrointestinal symptoms and findings of a laryngopharyngeal-esophagogastric endoscopy with respect to the medicinal pre-therapy;
- to gain insight into the currently used treatment strategies with esomeprazole depending on endoscopic findings.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00612404
|Study Chair:||Kai Richter, MD||Medical Department AstraZeneca Germany|